MDedge Cardiocast

New LDL-lowering drug is under FDA review


Listen Later

This week in MDedge Cardiocast: A novel drug lowers LDL in on top of maximums statins, invasive cardiology is a top money maker for hospitals, a meta-analysis parses the heart and kidney benefits of new diabetes drugs, and the AHA warns that heart-harming toxins may hurt hookah smokers.

...more
View all episodesView all episodes
Download on the App Store

MDedge CardiocastBy MDedge

  • 4.9
  • 4.9
  • 4.9
  • 4.9
  • 4.9

4.9

16 ratings